RR
Rajappa Ravichandran
About Rajappa Ravichandran
Data last updated:
Rajappa Ravichandran is a Managing Director at Octis Research Laboratories Private Limited (since 2006) and Director at G-Tab Pharma Private Limited (since 2023). The companies operate in Pharma and Paper. The largest current company by reported revenue is Octis Research Laboratories Private Limited at ₹56.3 Lakh (FY 2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 05 Apr 2006 | 2006 | ₹56.3 Lakh (FY 2018) | Active | |
| Director | 27 Dec 2023 | 2023 | Active |
Board colleagues of Rajappa Ravichandran
| Name | DIN | Company | Designation |
|---|---|---|---|
| Venugopal Ananthanarayanan Thangaraj | 02603568 | Octis Research Laboratories Private Limited | Director |
| Baskaran | 08968171 | G-Tab Pharma Private Limited | Director |
| Ravichandran Radhika | 10441269 | G-Tab Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajappa Ravichandran
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajappa Ravichandran
Rajappa Ravichandran currently holds 2 directorships: Octis Research Laboratories Private Limited (Managing Director, since 05 Apr 2006, revenue ₹56.3 Lakh (FY 2018)); G-Tab Pharma Private Limited (Director, since 27 Dec 2023).
Rajappa Ravichandran was first appointed on 05 Apr 2006 as Managing Director at Octis Research Laboratories Private Limited. The most recent appointment on record is 27 Dec 2023 at G-Tab Pharma Private Limited.
The current boards of Rajappa Ravichandran's companies include Venugopal Ananthanarayanan Thangaraj (Octis Research Laboratories Private Limited), Baskaran (G-Tab Pharma Private Limited), Ravichandran Radhika (G-Tab Pharma Private Limited).